[ad_1]
Jakarta, CNBC Indonesia – World Health Organization (WHO) chief scientist Soumya swaminathan praised China’s Covid-19 vaccine, which has shown positive results in fighting corona in clinical trials. So how is the development of the Chinese vaccine?
In his presentation, Soumya Swaminathan said that the Chinese vaccine could help the goal of eradicating Covid-19 in the world in the near future.
“WHO is working to ensure equitable access to the Covid-19 vaccine globally, believing that this is the fastest way to end the pandemic and accelerate the global economic recovery. China’s vaccines can help achieve that. target in the near future, as some vaccines have been shown to be successful in clinical trials. ”Swaminathan, reported on Chinese television CGTN, was quoted on Friday (09/25/2020).
China itself has four vaccine candidates developed by three companies. Namely, Sinovac Biotech, CanSino Biological, Sinopharm and the Wuhan Institute of Biological Products and Sinopharm and the Beijing Institute of Biological Products.
 Photo: Infographic / Knowing CoronaVac, Chinese Corona vaccine tested in RI / Arie Pratama |
According to WHO data, the four Chinese vaccines under development have entered phase three or final phase clinical trials. If a clinical trial involving a large number of volunteers is successful, the company will only have to apply for distribution permits from the health authorities of several countries.
Quoted from the Washington Post, the Chinese vaccine has been injected into thousands of people. This vaccine injection is an emergency use program whose license was issued on July 22.
Some of the Chinese citizens who have been injected with the vaccine in this program are the military, employees in border areas, health workers and vaccine development employees, and Chinese diplomats in other countries.
According to Zheng Zhongwei, head of China’s coronavirus vaccine development program, authorities are considering expanding delivery of the vaccine this fall to employees of the food market, transportation system and service industry.
“To prevent the spread of the disease in the fall and winter, we are considering a moderate expansion of the program. The aim is to establish an immune barrier between specific groups of the population,” Zhongwei said.
China Center for Disease Control and Prevention (CDC) principal investigator Wu Guizhen estimates that the Chinese vaccine will be ready for public use in November or December 2020.
According to him, clinical trials of several candidate vaccines are proceeding smoothly and preparations will be made for mass production of vaccines.
“I joined this experimental group and received injections last April.” Wu Guizhen said. “I feel good in the last months, nothing abnormal. The inoculation process does not cause pain in the body.”
(roy / dru)
